VINYLIDENE CHLORIDE-METHYL METHACRYLATE COPOLYMER
General Information
Mainterm | VINYLIDENE CHLORIDE-METHYL METHACRYLATE COPOLYMER |
CAS Reg.No.(or other ID) | 25120-29-0 |
Regnum |
175.105 175.320 176.170 176.180 177.1010 175.360 177.1200 177.1630 178.3790 |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 168296 |
IUPAC Name | 1,1-dichloroethene;methyl 2-methylprop-2-enoate |
InChI | InChI=1S/C5H8O2.C2H2Cl2/c1-4(2)5(6)7-3;1-2(3)4/h1H2,2-3H3;1H2 |
InChI Key | TVONSGOSXKGEKQ-UHFFFAOYSA-N |
Canonical SMILES | CC(=C)C(=O)OC.C=C(Cl)Cl |
Molecular Formula | C7H10Cl2O2 |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 197.055 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 2 |
Complexity | 121.0 |
CACTVS Substructure Key Fingerprint | A A A D c c B g M A A G A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A G g I A A A A A D A K A g I I C C A A A B A C I A g D S C A A A A A A A A A A A A A E A A E A A B A A A I Q A A A A A A A A A A I I A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 26.3 |
Monoisotopic Mass | 196.006 |
Exact Mass | 196.006 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 11 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 2 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9094 |
Human Intestinal Absorption | HIA+ | 0.9905 |
Caco-2 Permeability | Caco2+ | 0.6012 |
P-glycoprotein Substrate | Non-substrate | 0.8134 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8707 |
Non-inhibitor | 0.9642 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.9140 |
Distribution | ||
Subcellular localization | Mitochondria | 0.6761 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8651 |
CYP450 2D6 Substrate | Non-substrate | 0.9258 |
CYP450 3A4 Substrate | Non-substrate | 0.5622 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8256 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8328 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9340 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.7009 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8557 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8548 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9689 |
Non-inhibitor | 0.9627 | |
AMES Toxicity | AMES toxic | 0.8724 |
Carcinogens | Carcinogens | 0.6996 |
Fish Toxicity | High FHMT | 0.9298 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.6261 |
Honey Bee Toxicity | High HBT | 0.9030 |
Biodegradation | Not ready biodegradable | 0.5579 |
Acute Oral Toxicity | III | 0.4572 |
Carcinogenicity (Three-class) | Non-required | 0.6401 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -1.8872 | LogS |
Caco-2 Permeability | 1.3838 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 2.2360 | LD50, mol/kg |
Fish Toxicity | 0.7421 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | -0.1173 | pIGC50, ug/L |
From admetSAR